APA (7th ed.) Citation

Xiaoyu Wu, Zijun Bai, Hui Wang, Hanqing Wang, Dahai Hou, Yunzhu Xu, . . . Weiwei Tao. (2024). CRISPR-Cas9 gene editing strengthens cuproptosis/chemodynamic/ferroptosis synergistic cancer therapy. Elsevier.

Chicago Style (17th ed.) Citation

Xiaoyu Wu, et al. CRISPR-Cas9 Gene Editing Strengthens Cuproptosis/chemodynamic/ferroptosis Synergistic Cancer Therapy. Elsevier, 2024.

MLA (9th ed.) Citation

Xiaoyu Wu, et al. CRISPR-Cas9 Gene Editing Strengthens Cuproptosis/chemodynamic/ferroptosis Synergistic Cancer Therapy. Elsevier, 2024.

Warning: These citations may not always be 100% accurate.